A Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ABBV-552 in Participants with Mild Alzheimer's Disease

Grants and Contracts Details

StatusActive
Effective start/end date9/6/239/6/25

Funding

  • AbbVie Incorporated: $2.00